Typicality: | 0.311 |
Saliency: | 0.145 |
in unit dose form | 2 | other |
invention → be directed to → pharmaceutical compositions | 5 |
invention → be directed to → pharmaceutical composition | 4 |
negative | neutral | positive |
0.068 | 0.798 | 0.134 |
Raw frequency | 9 |
Normalized frequency | 0.145 |
Modifier score | 0.500 |
Perplexity | 46.935 |